TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
VTRS

Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.80$ +2.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 382 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VTRS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,201 350 453 568 549 496 622 430 654 636 -40 669 488 687 291 380 525 36 849 559 1,086 523 1,139 803 869 143 971 515 834 479 615 379 827 483 536 220 745 816 388 382 2,331
446 408 416 421 430 461 469 460 485 475 471 461 468 548 415 416 432 633 1,423 1,317 1,017 750 736 722 700 870 730 687 679 644 691 786 670 746 665 678 689 767 676 672 2,804
19 18 23 19 22 11 21 -0.8 -27 5.3 18 17 16 – 19 15 15 29 33 31 25 23 28 29 29 30 43 39 43 56 47 35 32 32 55 37 36 49 48 39 172
– – – – – – – – – – – – – 310 29 45 -19 648 395 531 274 479 13 -109 196 -1,164 46 -16 -185 – – – – – – – – – – – –
224 -768 189 -104 -289 -508 170 -230 -23 -303 -60 -51 -171 -1,188 -173 -120 -74 -328 69 -1,009 -525 -340 -15 -129 -377 -401 -31 -411 8.3 -277 -187 -215 139 155 -222 -982 126 -1,426 -703 -347 -2,350
119 151 58 51 47 120 31 45 62 115 53 44 42 120 43 54 38 117 53 89 132 221 72 90 116 166 83 89 102 201 51 59 85 153 76 54 100 265 40 53 458
-5,780 -539 -177 -452 -127 -221 -429 -304 -302 -176 -76 -158 -177 -115 -146 -75 -59 -22 236 -17 -118 -219 -67 -82 -115 1,785 -750 -77 -54 116 -154 376 1,748 -169 -65 -53 -99 -211 277 -52 -84
– – – – – – – – – – – – – – – – 133 133 133 133 133 133 145 146 146 146 144 144 144 144 143 146 143 143 143 140 140 138 140 140 558
-0.2 -4.6 -6.1 -1.3 – -500 -432 -1.2 – – -7.1 -1.2 -0.1 – -5.0 -2.1 – -0.8 -7.8 -5.7 -3.6 -0.3 -0.3 -3.3 -0.2 -3.9 -250 -143 -2.6 0.3 -250 -3.4 3.4 0.0 -175 -175 -65 -85 0.0 -150 -300
– – – – – – – – – – – – – -450 0.1 -556 0.4 154 -1,064 -87 -740 -215 -838 -628 -614 -1,201 -546 -182 -23 – – – -1,536 -1,376 1.4 0.0 0.3 -1.6 0.0 -922 -924
-531 -45 -576 -255 -423 -639 -121 -169 -225 -576 -40 -532 -133 -464 -25 -584 -146 149 -1,100 -686 -878 -349 -1,009 -780 -759 -1,331 -975 -304 -98 -926 -426 -848 -1,637 -1,420 -467 -362 -228 -236 -204 -1,243 -1,911
-5,105 -258 -139 -111 2.0 -381 75 -61 119 -114 -158 -18 162 117 97 -263 342 183 -37 -134 83 -56 51 -88 -19 612 -752 121 680 -318 22 -97 962 -1,144 20 -189 436 345 456 -914 322
1,082 199 395 517 502 376 591 385 592 521 -93 625 445 567 248 326 487 -81 796 470 954 302 1,067 713 753 -23 889 426 732 279 564 320 741 329 459 166 645 551 348 329 1,873

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?